Lineus Medical Announces a Reduction in Price for SafeBreak Vascular
Jersey Desk/10274825

FAYETTEVILLE, Ark. - JerseyDesk -- Lineus Medical announces a significant reduction in price of nearly 15% for its flagship product, SafeBreak Vascular, in the United States. After creating a new device classification with the FDA and becoming the first break-away device available for IV lines in the US, SafeBreak Vascular was first released with a list price of $6.90. Since its release, increased sales volume and concentrated efforts toward manufacturing efficiencies support a price adjustment with a new list price of $5.90, effective on September 1^st, 2024.

SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications¹.  When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money¹.

More on Jersey Desk

• Emory Healthcare Systemwide Allied Health Hiring Event at the High Museum of Art
• TurnMississippiBlue.org Pledges A New Way Forward
• Thrive Leadership Institute, Inc. Partners with the City of East Orange to Empower Local Businesses
• HandicapMD Expands Leading Telemedicine Services for Disabled Parking Permits in Florida
• Essex County's Anna D. Banks to Help Train New Facilitators in Global Transformation Effort

"A large focus of our strategy is maximizing our economic value proposition for the hospital." Lineus Medical's Vice President of Sales, Larry Hayes comments, "Reducing our price allows for both current and new accounts to take advantage of cost savings, and in doing so, we are making it easier for hospitals to invest in improved vascular access care for their patients."

Vance Clement, CEO of Lineus Medical, stated, "Inflation is hitting everyone, and we are all used to prices going up.  This is especially true in healthcare, where prices never go down. However, SafeBreak, which is proudly made in the USA, is changing that. As we continue to grow, we will keep investing in manufacturing so that we can lower the cost of SafeBreak again in the future."

Lineus Medical is committed to improving patient safety and advancing vascular access care and believes that this price reduction is another important step in our mission to remove the pains associated with medical lines.  Anyone interested in SafeBreak Vascular's price reduction can visit our website www.lineusmed.com to learn more.

More on Jersey Desk

• MAGA Candidate William O'Hanlon Files Complaint Alleging Election Interference and Fraud Directed by Acting Mayor Laurie Burns
• Democracy at Work & The Left Forum Presents Seminar with Professor Richard D. Wolff based on "Understanding Capitalism"
• Decorate for Fall with Braided Rugs
• Dasti & Staiger Welcome New Associate Attorney, Damian B. Majewski
• Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology USA - English USA - English USA - español Japan - Japanese

About Lineus Medical

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications¹. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.